Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Nicola Principi & Susanna Esposito. (2019) Experimental and investigational drugs for the treatment of acute otitis media. Expert Opinion on Investigational Drugs 28:8, pages 687-694.
Read now
Read now
Marwa Ghazaly & Simon Nadel. (2018) Overview of prevention and management of acute bronchiolitis due to respiratory syncytial virus. Expert Review of Anti-infective Therapy 16:12, pages 913-928.
Read now
Read now
Sophie K. Wong, Abby Li, Krista L. Lanctôt & Bosco Paes. (2018) Adherence and outcomes: a systematic review of palivizumab utilization. Expert Review of Respiratory Medicine 12:1, pages 27-42.
Read now
Read now
Articles from other publishers (35)
Amr Kandeel, Manal Fahim, Ola Deghedy, Wael H. Roshdy, Mohamed K. Khalifa, Rabeh El Shesheny, Ahmed Kandeil, Saly Wagdy, Amel Naguib, Salma Afifi & Khaled Abdelghaffar. (2023) Multicenter study to describe viral etiologies, clinical profiles, and outcomes of hospitalized children with severe acute respiratory infections, Egypt 2022. Scientific Reports 13:1.
Crossref
Crossref
Lucie Jelínková, Bryce Roberts, Diane T. Ajayi, David S. Peabody & Bryce Chackerian. (2023) The Immunogenicity of a VLP-based Malaria Vaccine Targeting CSP in Pregnant and Neonatal Mice. Biomolecules 13:2, pages 202.
Crossref
Crossref
Arabella S V Stuart, Miia Virta, Kristi Williams, Ilkka Seppa, Robyn Hartvickson, Melanie Greenland, Edmund Omoruyi, Arangassery Rosemary Bastian, Wouter Haazen, Nadine Salisch, Efi Gymnopoulou, Benoit Callendret, Saul N Faust, Matthew D Snape & Esther Heijnen. (2023) Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18–50 Years and RSV-Seropositive Children 12–24 Months. The Journal of Infectious Diseases 227:1, pages 71-82.
Crossref
Crossref
Gemma L. Saravanos, Peter Hsu, David Isaacs, Kristine Macartney, Nicholas J. Wood & Philip N. Britton. (2021) Respiratory Syncytial Virus-attributable Deaths in a Major Pediatric Hospital in New South Wales, Australia, 1998–2018. Pediatric Infectious Disease Journal 41:3, pages 186-191.
Crossref
Crossref
Hae-Ji Kang, Min-Ju Kim, Ki-Back Chu, Su-Hwa Lee, Eun-Kyung Moon & Fu-Shi Quan. (2021) Passive Immunity and Antibody Response Induced by Toxoplasma gondii VLP Immunization. Vaccines 9:5, pages 425.
Crossref
Crossref
. (2021)
New long‐acting monoclonal antibody reduces
RSV
infections in healthy preterm infants
. Journal of Paediatrics and Child Health 57:4, pages 593-593.
Crossref
Crossref
Jacques Gaillat. (2020) Where are the keys to improve vaccine uptake in adults and elders in European countries?. Aging Clinical and Experimental Research 33:4, pages 1123-1131.
Crossref
Crossref
Jorge A. Soto, Nicolás M. S. Gálvez, Gaspar A. Pacheco, Susan M. Bueno & Alexis M. Kalergis. (2020) Antibody development for preventing the human respiratory syncytial virus pathology. Molecular Medicine 26:1.
Crossref
Crossref
J. Tyler Kinder, Carole L. Moncman, Chelsea Barrett, Hong Jin, Nicole Kallewaard & Rebecca Ellis Dutch. (2020) Respiratory Syncytial Virus and Human Metapneumovirus Infections in Three-Dimensional Human Airway Tissues Expose an Interesting Dichotomy in Viral Replication, Spread, and Inhibition by Neutralizing Antibodies. Journal of Virology 94:20.
Crossref
Crossref
Yu Zheng, Lijun Bian, Huiting Zhao, Yulan Liu, Jingcai Lu, Dawei Liu, Ke Zhang, Yueshuang Song, Yusi Luo, Chunlai Jiang, Yan Chen, Yong Zhang & Wei Kong. (2020) Respiratory Syncytial Virus F Subunit Vaccine With AS02 Adjuvant Elicits Balanced, Robust Humoral and Cellular Immunity in BALB/c Mice. Frontiers in Immunology 11.
Crossref
Crossref
M. Pamela GriffinYuan YuanTherese TakasJoseph B. DomachowskeShabir A. MadhiPaolo ManzoniEric A.F. SimõesMark T. EsserAnis A. KhanFilip DubovskyTonya VillafanaJohn P. DeVincenzo. (2020) Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants. New England Journal of Medicine 383:5, pages 415-425.
Crossref
Crossref
Hui Liu, Bin Lu, David E. Tabor, Andrey Tovchigrechko, Deidre Wilkins, Hong Jin, Shabir A. Madhi, Nasiha Soofie, Mark T. Esser & Marta C. Nunes. (2020) Characterization of human respiratory syncytial virus (RSV) isolated from HIV‐exposed‐uninfected and HIV‐unexposed infants in South Africa during 2015‐2017. Influenza and Other Respiratory Viruses 14:4, pages 403-411.
Crossref
Crossref
Asuncion Mejias, Rosa Rodríguez-Fernández, Silvia Oliva, Mark E. Peeples & Octavio Ramilo. (2020) The journey to a respiratory syncytial virus vaccine. Annals of Allergy, Asthma & Immunology 125:1, pages 36-46.
Crossref
Crossref
Sandra Fuentes, Megan Hahn, Katarina Chilcote, Roy F Chemaly, Dimpy P Shah, Xunyan Ye, Vasanthi Avadhanula, Pedro A Piedra, Hana Golding & Surender Khurana. (2020) Antigenic Fingerprinting of Respiratory Syncytial Virus (RSV)-A–Infected Hematopoietic Cell Transplant Recipients Reveals Importance of Mucosal Anti–RSV G Antibodies in Control of RSV Infection in Humans. The Journal of Infectious Diseases 221:4, pages 636-646.
Crossref
Crossref
Stanley A. Plotkin. (2020) Updates on immunologic correlates of vaccine-induced protection. Vaccine 38:9, pages 2250-2257.
Crossref
Crossref
Tracy J. Ruckwardt, Michelle C. Crank, Kaitlyn M. Morabito & Barney S. Graham. 2020. Mucosal Vaccines. Mucosal Vaccines
665
676
.
Bernard Gonik. (2019) The Burden of Respiratory Syncytial Virus Infection in Adults and Reproductive-Aged Women. Global Health: Science and Practice 7:4, pages 515-520.
Crossref
Crossref
Asuncion Mejias, Rosa Rodriguez-Fernandez, Mark E. Peeples & Octavio Ramilo. (2019) Respiratory Syncytial Virus Vaccines. The Pediatric Infectious Disease Journal 38:10, pages e266-e269.
Crossref
Crossref
Tracy J. Ruckwardt, Kaitlyn M. Morabito & Barney S. Graham. (2019) Immunological Lessons from Respiratory Syncytial Virus Vaccine Development. Immunity 51:3, pages 429-442.
Crossref
Crossref
Seyhan Boyoglu-Barnum, Tatiana Chirkova & Larry J. Anderson. (2019) Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development. Frontiers in Immunology 10.
Crossref
Crossref
Angela M Bengtson, Alan M Sanfilippo, Brenna L Hughes & David A Savitz. (2019) Maternal immunisation to improve the health of HIV-exposed infants. The Lancet Infectious Diseases 19:4, pages e120-e131.
Crossref
Crossref
Diego R. Hijano, Luan D. Vu, Lawrence M. Kauvar, Ralph A. Tripp, Fernando P. Polack & Stephania A. Cormier. (2019) Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity. Frontiers in Immunology 10.
Crossref
Crossref
Bin Lu, Hui Liu, David E. Tabor, Andrey Tovchigrechko, Yanping Qi, Alexey Ruzin, Mark T. Esser & Hong Jin. (2019) Emergence of new antigenic epitopes in the glycoproteins of human respiratory syncytial virus collected from a US surveillance study, 2015–17. Scientific Reports 9:1.
Crossref
Crossref
Emily Phung, Lauren Chang, Kaitlyn Morabito, Masaru Kanekiyo, Man Chen, Deepika Nair, Azad Kumar, Grace Chen, Julie Ledgerwood, Barney Graham & Tracy Ruckwardt. (2019) Epitope-Specific Serological Assays for RSV: Conformation Matters. Vaccines 7:1, pages 23.
Crossref
Crossref
Mariana Guerra-Maupome, Mitchell V. Palmer, Jodi L. McGill & Randy E. Sacco. (2019) Utility of the Neonatal Calf Model for Testing Vaccines and Intervention Strategies for Use against Human RSV Infection. Vaccines 7:1, pages 7.
Crossref
Crossref
Helen H. Mao & Shoubai Chao. 2020. Current Applications of Pharmaceutical Biotechnology. Current Applications of Pharmaceutical Biotechnology
155
188
.
Anna C. Vittucci, Paola Zangari, Claudia Ciarlitto, Chiara Di Camillo, Annalisa Grandin, Nicola Cotugno, Maria R. Marchili & Alberto Villani. (2018) Active prophylaxis for respiratory syncytial virus: current knowledge and future perspectives. Minerva Pediatrica 70:6.
Crossref
Crossref
Antonio Del Vecchio, Caterina Franco, Karin Del Vecchio, Angela Umbaldo, Letizia Capasso & Francesco Raimondi. (2018) RSV prophylaxis in premature infants. Minerva Pediatrica 70:6.
Crossref
Crossref
Lan Zhang, Eberhard Durr, Jennifer D. Galli, Scott Cosmi, Pedro J. Cejas, Bin Luo, Sinoeun Touch, Paul Parmet, Arthur Fridman, Amy S. Espeseth & Andrew J. Bett. (2018) Design and characterization of a fusion glycoprotein vaccine for Respiratory Syncytial Virus with improved stability. Vaccine 36:52, pages 8119-8130.
Crossref
Crossref
Manjiri Joshi & Robert M R Tulloh. (2018) Respiratory virus prophylaxis in congenital heart disease. Future Cardiology 14:5, pages 417-425.
Crossref
Crossref
Alexey Ruzin, Susan T. Pastula, Elizabeth Levin-Sparenberg, Xiaohui Jiang, Jon Fryzek, Andrey Tovchigrechko, Bin Lu, Yanping Qi, Hui Liu, Hong Jin, Li Yu, Judith Hackett, Tonya Villafana & Mark T. Esser. (2018) Characterization of circulating RSV strains among subjects in the OUTSMART-RSV surveillance program during the 2016-17 winter viral season in the United States. PLOS ONE 13:7, pages e0200319.
Crossref
Crossref
Qing Zhu, Bin Lu, Patrick McTamney, Susan Palaszynski, Seme Diallo, Kuishu Ren, Nancy D Ulbrandt, Nicole Kallewaard, Weijia Wang, Fiona Fernandes, Steve Wong, Catherine Svabek, Brian Moldt, Mark T Esser, Hong Jing & JoAnn A Suzich. (2018) Prevalence and Significance of Substitutions in the Fusion Protein of Respiratory Syncytial Virus Resulting in Neutralization Escape From Antibody MEDI8897. The Journal of Infectious Diseases 218:4, pages 572-580.
Crossref
Crossref
Eric A. F. Simões, Louis Bont, Paolo Manzoni, Brigitte Fauroux, Bosco Paes, Josep Figueras-Aloy, Paul A. Checchia & Xavier Carbonell-Estrany. (2018) Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children. Infectious Diseases and Therapy 7:1, pages 87-120.
Crossref
Crossref
Ruth A Karron & Heather J Zar. (2018) Determining the outcomes of interventions to prevent respiratory syncytial virus disease in children: what to measure?. The Lancet Respiratory Medicine 6:1, pages 65-74.
Crossref
Crossref
Tracy J. Ruckwardt, Peter L. Collins & Barney S. Graham. 2018. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.